Alfred Sandrock Voyager Therapeutics, Inc. (VYGR) insider trading activity

VYGR Quotes by TradingView

Alfred Sandrock is President and CEO of Voyager Therapeutics, Inc.. Currently has a direct ownership of 322,839 shares of VYGR, which is worth approximately $1.75 Million. The most recent transaction as insider was on Apr 02, 2024, when has been sold 12,115 shares (Common Stock) at a price of $9.86 per share, resulting in proceeds of $119,453. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 323K
0% 3M change
50.42% 12M change
Total Value Held $1.75 Million

Alfred Sandrock Transaction History

Date Transaction Value Shares Traded Shares Held Form
Apr 02 2024
SELL
Open market or private sale
$119,453 $9.86 p/Share
12,115 Reduced 3.62%
322,839 Common Stock
Feb 21 2024
SELL
Open market or private sale
$97,226 $7.46 p/Share
13,033 Reduced 3.75%
334,954 Common Stock
Feb 09 2024
BUY
Grant, award, or other acquisition
-
130,000 Added 27.2%
347,987 Common Stock
Apr 03 2023
SELL
Open market or private sale
$58,231 $7.83 p/Share
7,437 Reduced 3.35%
214,618 Common Stock
Feb 17 2023
BUY
Grant, award, or other acquisition
-
120,000 Added 35.08%
222,055 Common Stock
Mar 22 2022
BUY
Grant, award, or other acquisition
-
100,000 Added 50.0%
100,000 Common Stock

Also insider at

BIIB
BIOGEN INC. Healthcare
Head of Research & Development
AS

Alfred Sandrock

President and CEO
Cambridge, MA

Track Institutional and Insider Activities on VYGR

Follow Voyager Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells VYGR shares.

Notify only if

Insider Trading

Get notified when an Voyager Therapeutics, Inc. insider buys or sells VYGR shares.

Notify only if

News

Receive news related to Voyager Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on VYGR